Stocks and Investing Stocks and Investing
Tue, December 15, 2020

David Lewis Maintained (AVNS) at Sell with Increased Target to $45 on, Dec 15th, 2020


Published on 2024-10-27 15:01:14 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Increased Target from $36 to $45 on, Dec 15th, 2020.

David has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Matthew Mishan of "Keybanc" Maintained at Buy with Increased Target to $47 on, Wednesday, November 4th, 2020
Contributing Sources